REGENERON PHARMACEUTICALS, INC. Cost of Revenue 2008-2019 | REGN
What is cost of revenue?
Cost of revenue includes the direct costs attributable to producing goods or delivering services sold by the company.
What is REGENERON PHARMACEUTICALS, INC.'s current cost of revenue?
REGENERON PHARMACEUTICALS, INC. (REGN) annual cost of revenue for 2019 was $402.8M, a 69.60% increase from 2018. REGENERON PHARMACEUTICALS, INC. cost of revenue for the quarter ending March 31, 2018 was $69.2M.
What was REGENERON PHARMACEUTICALS, INC.'s cost of revenue in 2018?
REGENERON PHARMACEUTICALS, INC. annual cost of revenue for 2018 was $237.5M, a 17.28% increase from 2017.
What was REGENERON PHARMACEUTICALS, INC.'s cost of revenue in 2017?
REGENERON PHARMACEUTICALS, INC. annual cost of revenue for 2017 was $202.5M, a 4.05% increase from 2016.
What is REGENERON PHARMACEUTICALS, INC.'s 5-year cost of revenue CAGR?
REGENERON PHARMACEUTICALS, INC. cost of revenue grew at a compound annual growth rate (CAGR) of 25.57% from FY2014 to FY2019, going from $129.0M to $402.8M over 5 years.
Year-over-year comparison from 10-K annual reports